Bromelain: A potential therapeutic application in SARS-CoV-2 infected patients
<p>The SARS-CoV-2 infection has led to a global pandemic which has led to almost 4 million deaths worldwide. However, to date, a specific antiviral drug does not exist to treat the disease and control the virus. Here, we focus on the potential use of bromelain in line with its anti-oxidant, an...
Saved in:
Main Authors: | Serkan Sayıner (Author), Ayliz Velioğlu-Öğünç (Author), Ahmet Özer Şehirli (Author) |
---|---|
Format: | Book |
Published: |
Annals of Antivirals and Antiretrovirals - Peertechz Publications,
2021-06-19.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastrointestinal and hepatic involvement in patients with SARS-CoV-2 infection
by: Gupta Rama, et al.
Published: (2021) -
Therapeutic implications in patients with subacute thyroiditis in the SARS-CoV-2 era
by: Katrin Henke, et al.
Published: (2022) -
Updates in Management of SARS-CoV-2 Infection
Published: (2022) -
Potential Anti-SARS-CoV-2 Molecular Strategies
Published: (2023) -
On the possibility of using hyperbaric oxygenation in the treatment of sars-cov-2 infected patients
by: Pavel Savilov
Published: (2020)